Last SFr.56.30 CHF
Change Today -0.65 / -1.14%
Volume 31.3K
ATLN On Other Exchanges
Symbol
Exchange
OTC US
SIX Swiss Ex
SIX Swiss Ex
Frankfurt
OTC US
As of 3:15 AM 06/20/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-Paul Clozel M.D.

Founder, Chief Executive Officer, Member of Management Board and Director, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 17 board members in 3 different organizations across 3 different industries.

See Board Relationships
57SFr.5,180,923
As of Fiscal Year 2012

Background*

Mr. Jean-Paul Clozel, MD founded Actelion Pharmaceuticals U.S., Inc. in 1997 and has been its Chief Executive Officer since April 2000. Mr. Clozel is the Founder of Actelion Ltd., (Actelion AG ) and has been its Chief Executive Officer since 1999 and serves as a Member of its Management Board. He was a Practicing Cardiologist for 11 years, from 1974 to 1985. He served as the Head of Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche for 12 ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123

Switzerland

Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

Founder, Chief Executive Officer, Member of Management Board and Director
Founder, Chief Executive Officer, Member of The Board and Member of Executive Committee
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

SalarySFr.1,108,550
BonusSFr.1,408,968
Total Annual CompensationSFr.2,517,518

Stock Options*

Restricted Stock AwardsSFr.539,597
All Other CompensationSFr.1,471,012

Total Compensation*

Total Annual Cash CompensationSFr.3,988,530
Total Short Term CompensationSFr.2,517,518
Other Long Term CompensationSFr.2,010,609
Total Calculated CompensationSFr.5,180,923
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.56.35 CHF -0.60

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Bonney B.A.Chief Executive Officer and Director
Cubist Pharmaceuticals Inc.
$700.0K
Rajiv De Silva Chief Executive Officer, President and Director
Endo Health Solutions Inc.
--
Jason T. Flatley Chief Executive Officer, President and Director
Illumina Inc.
$1.0M
Martine A. Rothblatt Ph.D., J.D., MBAFounder, Chairman and Chief Executive Officer
United Therapeutics Corporation
$959.6K
Ulf Arne Wiinberg Chief Executive Officer, President and Member of the Board of Management
H. Lundbeck A/S
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.